Activity of cetuximab as single agent in a patient with relapsed multiple myeloma.
Böll
Boris
B
Eichenauer
Dennis A
DA
Von Tresckow
Bastian
B
Peine
Denissa
D
Hallek
Michael
M
Engert
Andreas
A
Hübel
Kai
K
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000068818:Cetuximab; D066246:ErbB Receptors / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008024:Ligands; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D008024:Ligands; D066246:ErbB Receptors; D000068818:Cetuximab